BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9036876)

  • 1. K-ras and p53 mutations in hereditary non-polyposis colorectal cancers.
    Losi L; Ponz de Leon M; Jiricny J; Di Gregorio C; Benatti P; Percesepe A; Fante R; Roncucci L; Pedroni M; Benhattar J
    Int J Cancer; 1997 Feb; 74(1):94-6. PubMed ID: 9036876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer.
    Konishi M; Kikuchi-Yanoshita R; Tanaka K; Muraoka M; Onda A; Okumura Y; Kishi N; Iwama T; Mori T; Koike M; Ushio K; Chiba M; Nomizu S; Konishi F; Utsunomiya J; Miyaki M
    Gastroenterology; 1996 Aug; 111(2):307-17. PubMed ID: 8690195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis.
    Young J; Simms LA; Biden KG; Wynter C; Whitehall V; Karamatic R; George J; Goldblatt J; Walpole I; Robin SA; Borten MM; Stitz R; Searle J; McKeone D; Fraser L; Purdie DR; Podger K; Price R; Buttenshaw R; Walsh MD; Barker M; Leggett BA; Jass JR
    Am J Pathol; 2001 Dec; 159(6):2107-16. PubMed ID: 11733361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study.
    Gylling A; Abdel-Rahman WM; Juhola M; Nuorva K; Hautala E; Järvinen HJ; Mecklin JP; Aarnio M; Peltomäki P
    Gut; 2007 Jul; 56(7):926-33. PubMed ID: 17267619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
    Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP
    J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of OGG1, MYH, MTH1 in FAP, HNPCC and sporadic colorectal cancer patients: R154H OGG1 polymorphism is associated with sporadic colorectal cancer patients.
    Kim IJ; Ku JL; Kang HC; Park JH; Yoon KA; Shin Y; Park HW; Jang SG; Lim SK; Han SY; Shin YK; Lee MR; Jeong SY; Shin HR; Lee JS; Kim WH; Park JG
    Hum Genet; 2004 Nov; 115(6):498-503. PubMed ID: 15449173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No major difference in K-ras and p53 abnormalities in sporadic and hereditary nonpolyposis colorectal adenomas.
    Voskuil DW; Kampman E; van Geloof W; Grubben M; Kok F; van Muijen G; Nagengast F; Vasen H; van't Veer P
    Dig Dis Sci; 2000 Nov; 45(11):2187-94. PubMed ID: 11215737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic frameshift mutations in DNA mismatch repair and proapoptosis genes in hereditary nonpolyposis colorectal cancer.
    Yamamoto H; Sawai H; Weber TK; Rodriguez-Bigas MA; Perucho M
    Cancer Res; 1998 Mar; 58(5):997-1003. PubMed ID: 9500462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression.
    Calistri D; Rengucci C; Seymour I; Lattuneddu A; Polifemo AM; Monti F; Saragoni L; Amadori D
    J Cell Physiol; 2005 Aug; 204(2):484-8. PubMed ID: 15702478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic and genetic features of nonfamilial colorectal carcinomas with DNA replication errors.
    Senba S; Konishi F; Okamoto T; Kashiwagi H; Kanazawa K; Miyaki M; Konishi M; Tsukamoto T
    Cancer; 1998 Jan; 82(2):279-85. PubMed ID: 9445183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
    Shin KH; Park YJ; Park JG
    Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of Kruppel-like factor 6 (KLF6) mutation in the development of nonpolypoid colorectal carcinoma.
    Mukai S; Hiyama T; Tanaka S; Yoshihara M; Arihiro K; Chayama K
    World J Gastroenterol; 2007 Aug; 13(29):3932-8. PubMed ID: 17663506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
    Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
    Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsatellite instability in multiple colorectal tumors.
    Pedroni M; Tamassia MG; Percesepe A; Roncucci L; Benatti P; Lanza G; Gafà R; Di Gregorio C; Fante R; Losi L; Gallinari L; Scorcioni F; Vaccina F; Rossi G; Cesinaro AM; Ponz de Leon M
    Int J Cancer; 1999 Mar; 81(1):1-5. PubMed ID: 10077143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of germline hereditary non-polyposis colorectal cancer gene mutations in patients with multiple or early onset colorectal adenomas.
    Beck NE; Tomlinson IP; Homfray TF; Frayling IM; Hodgson SV; Bodmer WF
    Gut; 1997 Aug; 41(2):235-8. PubMed ID: 9301504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologic characterization of hereditary non-polyposis colorectal cancer. Nuclear ploidy, AgNOR count, microvessel distribution, oncogene expression, and grade-related parameters.
    Losi L; Fante R; Di Gregorio C; Aisoni ML; Lanza G; Maestri I; Roncucci L; Pedroni M; Ponz de Leon M
    Am J Clin Pathol; 1995 Mar; 103(3):265-70. PubMed ID: 7532909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.
    Johnson V; Volikos E; Halford SE; Eftekhar Sadat ET; Popat S; Talbot I; Truninger K; Martin J; Jass J; Houlston R; Atkin W; Tomlinson IP; Silver AR
    Gut; 2005 Feb; 54(2):264-7. PubMed ID: 15647192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location.
    Gervaz P; Bouzourene H; Cerottini JP; Chaubert P; Benhattar J; Secic M; Wexner S; Givel JC; Belin B
    Dis Colon Rectum; 2001 Mar; 44(3):364-72; discussion 372-3. PubMed ID: 11289282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA alterations in cells from hereditary non-polyposis colorectal cancer patients.
    Wu C; Akiyama Y; Imai K; Miyake S; Nagasaki H; Oto M; Okabe S; Iwama T; Mitamura K; Masumitsu H
    Oncogene; 1994 Mar; 9(3):991-4. PubMed ID: 8108146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.